Alzheimer’s Disease

★★★★★ Rated 4.9 stars from 900+ patient reviews
Elderly couple embracing tenderly by a window, reflecting love and support.

What is Alzheimer’s Disease?

Alzheimer’s disease is a progressive neurological condition that affects memory, thinking, and behavior. As the most common form of dementia, it accounts for 60-80% of all dementia cases. The disease gradually destroys brain cells, leading to cognitive decline that eventually interferes with daily activities and independence.

Early symptoms often include difficulty remembering recent conversations or events, misplacing items, and trouble finding the right words. As the condition advances, individuals may experience confusion, mood changes, difficulty with familiar tasks, and eventually require full-time care.

While Alzheimer’s disease primarily affects adults over 65, it is considered one of many chronic conditions, and early-onset cases can occur in individuals as young as their 40s or 50s.

Understanding where you or your loved one falls within the disease progression helps guide appropriate treatment and care planning.

Alzheimer’s Disease Symptoms

Here’s a complete list of warning signs to watch for in yourself or a loved one:

  • Memory loss that disrupts daily life
  • Difficulty planning or solving problems
  • Trouble completing familiar tasks
  • Confusion with time or place
  • Problems understanding visual images and spatial relationships
  • New difficulty with words in speaking or writing
  • Misplacing items and losing the ability to retrace steps
  • Decreased or poor judgment
  • Withdrawal from work or social activities
  • Changes in mood and personality

Alzheimer’s Disease Stages

Alzheimer’s disease progresses through distinct stages, each presenting unique challenges and care needs:

  1. Pre-clinical: Brain changes begin years before symptoms appear. No noticeable cognitive problems exist, albeit biomarkers may indicate disease presence.
  2. Pro-dromal: Very mild changes in memory and thinking emerge, but don’t significantly impact daily functioning.
  3. Mild Cognitive Impairment: Memory lapses become more frequent and noticeable to family members. Completing complex tasks becomes challenging.
  4. Mild Dementia: Clear cognitive difficulties affect work, social activities, and managing finances. Personality changes, confusion, and wandering are common.
  5. Moderate Dementia: Significant assistance becomes necessary for daily activities. Personality changes, confusion, and wandering are common.
  6. Severe Dementia: Round-the-clock care is required. Communication becomes extremely limited, and physical abilities decline substantially.
  7. End-Stage Dementia: Total dependence on caregivers for all aspects of care, including eating, bathing, and mobility.

Alzheimer’s Disease Treatment

At TwelveStone Health Partners, we offer Leqembi (lecanemab), a groundbreaking FDA-approved treatment that targets the underlying disease process rather than just managing symptoms. This innovative therapy works by reducing amyloid plaques in the brain—protein deposits strongly associated with Alzheimer’s progression.

Leqembi represents a significant advancement in Alzheimer’s care, offering hope for slowing cognitive decline in appropriate candidates. Our team carefully evaluates each patient to determine eligibility and provides comprehensive monitoring throughout treatment.

Beyond Leqembi, we develop personalized care plans that may include cognitive therapies, lifestyle modifications, and supportive medications to manage symptoms and maintain quality of life as long as possible.

Organizational Resources

The Alzheimer’s Association leads the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.

Learn more

The Alzheimer’s Foundation of America (AFA) provides support, services, and education to individuals, families, and caregivers affected by Alzheimer’s disease and related dementias nationwide, and funds research for better treatment and a cure.

Learn more

The Bright Focus Foundation is a nonprofit that funds groundbreaking research in an urgent effort to discover cures for Alzheimer’s disease, macular degeneration, and glaucoma.

Learn more

New Patient Resources

Contact TwelveStone Health Partners Today!

Ready to take the next step? 

Our caring team is here to answer your questions, discuss treatment options, and guide you toward the support you deserve. 

Contact us today to schedule a consultation and discover how TwelveStone Health Partners can help you face Alzheimer’s disease with confidence and hope.

nurse consulting patient

Frequently Asked Questions

The best treatment depends on disease stage and individual factors. FDA-approved options like Leqembi show promise in slowing progression, while other medications manage symptoms effectively.

Treatment combines medication, cognitive therapies, lifestyle modifications, and supportive care tailored to each patient’s needs and disease stage.

Average life expectancy after diagnosis ranges from 4 to 8 years, though some individuals live 20 years or longer, depending on various health factors.

The exact cause remains unknown, but it involves a combination of genetic, environmental, and lifestyle factors that trigger abnormal protein buildup in the brain.

Don’t argue, don’t reason, don’t remind. Instead, redirect, reassure, and respond to emotions rather than correcting facts; this approach reduces frustration for everyone.